Jason Mark Brooks

age:

52 years

appointments:

29 active

14 prior

primary industry:

Human health activities

about Jason

Since 2019, Mr Brooks has been a director of 43 companies, the current directorship have a combined turnover of approximately £2.6b.

Combined Valuation

£9.1b

Combined Turnover

£2.6b

active directorships over time

company
turnover
valuation
start
end
status
role
novartis pharmaceuticals uk limited£630.9m£1.4bMay 2019-OpenDirector
novartis pharmaceuticals uk limited£630.9m£1.4bMay 2019-OpenDirector
novartis pharmaceuticals uk limited£630.9m£1.4bMay 2019-OpenDirector
novartis pharmaceuticals uk limited£630.9m£1.4bMay 2019-OpenDirector
novartis grimsby limited£3.2m£491.2mMay 2019-OpenDirector
novartis grimsby limited£3.2m£491.2mMay 2019-OpenDirector
novartis grimsby limited£3.2m£491.2mMay 2019-OpenDirector
novartis grimsby limited£3.2m£491.2mMay 2019-OpenDirector
novartis uk limited-£344.8mMay 2019-OpenDirector
novartis uk limited-£344.8mMay 2019-OpenDirector
novartis uk limited-£344.8mMay 2019-OpenDirector
novartis uk limited-£344.8mMay 2019-OpenDirector
neutec pharma limited-£75mMay 2019-OpenDirector
neutec pharma limited-£75mMay 2019-OpenDirector
neutec pharma limited-£75mMay 2019-OpenDirector
neutec pharma limited-£75mMay 2019-OpenDirector
advanced accelerator applications (uk & ireland) limited£23.6m£12.2mMay 2019-OpenDirector
novartis europharm limited£36.6k£599.6kMay 2019-OpenDirector
ziarco pharma ltd--May 2019-OpenDirector
ziarco pharma ltd--May 2019-OpenDirector
ziarco group limited--May 2019-OpenDirector
ziarco group limited--May 2019-OpenDirector
gyroscope therapeutics holdings limited--Feb 2022-OpenDirector
ziarco group limited--May 2019-OpenDirector
gyroscope therapeutics limited--Feb 2022-OpenDirector